Oncopeptides' Series A Round

Oncopeptides raised a round of funding on May 21, 2013.

Oncopeptides is a clinical stage pharmaceutical development company working to enhance oncology therapies by creating cytosuperiors of existing basic cytotoxic compounds. The company is targeting mult…

Articles about Oncopeptides' Series A Round: